Neogenomics (NEO) Change in Acquisitions & Divestments (2020 - 2025)

Neogenomics (NEO) has 6 years of Change in Acquisitions & Divestments data on file, last reported at $9.0 million in Q3 2025.

• Quarterly Change in Acquisitions & Divestments rose 23.58% year-over-year to $9.0 million in Q3 2025, while the trailing twelve-month figure through Jun 2026 was $9.0 million (down 63.23% YoY) and the FY2025 annual result came in at $20.1 million, down 62.79% from the prior year.
• Change in Acquisitions & Divestments grew to $9.0 million in Q3 2025, from $3.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $40.4 million in Q1 2023 to a low of $3.0 million in Q2 2025.
• A 5-year average of $19.3 million and a median of $20.1 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2021 — Change in Acquisitions & Divestments jumped 673.94% — and 2025, when it plunged 85.29%.
• Tracing NEO's Change in Acquisitions & Divestments over 5 years: stood at $18.2 million in 2021, then surged by 48.64% to $27.1 million in 2022, then slipped by 10.52% to $24.3 million in 2023, then sank by 74.72% to $6.1 million in 2024, then jumped by 46.77% to $9.0 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $9.0 million (Q3 2025), $3.0 million (Q2 2025), and $8.1 million (Q1 2025), per Business Quant data.